Everest Medicines gets NMPA approval for Cardamyst NDA in adult PSVT
Everest Medicines Limited says China’s NMPA approved its Cardamyst (etripamil) NDA for treating PSVT in adults.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.